Classification and treatment of endothermal heat-induced thrombosis: Recommendations from the American Venous Forum and the Society for Vascular Surgery.
Administration, Oral
Anticoagulants
/ administration & dosage
Consensus
Evidence-Based Medicine
Fibrinolytic Agents
/ administration & dosage
Humans
Laser Therapy
/ adverse effects
Platelet Aggregation Inhibitors
/ administration & dosage
Radiofrequency Ablation
/ adverse effects
Treatment Outcome
Venous Insufficiency
/ surgery
Venous Thrombosis
/ diagnostic imaging
Journal
Journal of vascular surgery. Venous and lymphatic disorders
ISSN: 2213-3348
Titre abrégé: J Vasc Surg Venous Lymphat Disord
Pays: United States
ID NLM: 101607771
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
29
05
2020
accepted:
09
06
2020
pubmed:
6
10
2020
medline:
29
4
2021
entrez:
5
10
2020
Statut:
ppublish
Résumé
The American Venous Forum (AVF) and the Society for Vascular Surgery set forth these guidelines for the management of endothermal heat-induced thrombosis (EHIT). The guidelines serve to compile the body of literature on EHIT and to put forth evidence-based recommendations. The guidelines are divided into the following categories: classification of EHIT, risk factors and prevention, and treatment of EHIT. One major feature is to standardize the reporting under one classification system. The Kabnick and Lawrence classification systems are now combined into the AVF EHIT classification system. The novel classification system affords standardization in reporting but also allows continued combined evaluation with the current body of literature. Recommendations codify the use of duplex ultrasound for the diagnosis of EHIT. Risk factor assessments and methods of prevention including mechanical prophylaxis, chemical prophylaxis, and ablation distance are discussed. Treatment guidelines are tailored to the AVF EHIT class (ie, I, II, III, IV). Reference is made to the use of surveillance, antiplatelet therapy, and anticoagulants as deemed indicated, and the recommendations incorporate the use of the novel direct oral anticoagulants. Last, EHIT management as it relates to the great and small saphenous veins is discussed.
Identifiants
pubmed: 33012690
pii: S2213-333X(20)30343-7
doi: 10.1016/j.jvsv.2020.06.008
pii:
doi:
Substances chimiques
Anticoagulants
0
Fibrinolytic Agents
0
Platelet Aggregation Inhibitors
0
Types de publication
Journal Article
Practice Guideline
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
6-22Informations de copyright
Copyright © 2020 Society for Vascular Surgery, the American Venous Forum and the Authors. Published by Elsevier Inc. All rights reserved.